ČESKÁ UROLOGIE / CZECH UROLOGY – 4 / 2021

262 Ces Urol 2021; 25(4): 254–262 ORIGINÁLNÍ PRÁCE 8. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham‑controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 2021; 206: 1–9 9. Wasserbauer R, Pacik D, Varga G, Vit V, Jarkovsky J, Fedorko M. Short‑term outcomes of water va‑ por therapy (Rezūm) for BPH/LUTS in the first Czech cohort Urology Journal 2021; 18: 6843 https://doi org/10 22037/uj v18i 6843 [Epub ahead of print] 10. McVary KT, Roehrborn CG. Three‑year outcomes of the prospective, randomized controlled rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia Urology 2018; 111: 1–9 11. Siena G, Cindolo L, Ferrari G, et al. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study World J Urol 2021; 31: 1–6 12. McVary KT, Holland B, Beahrs JR. Water vapor thermal therapy to alleviate catheter‑dependent urinary retention secondary to benign prostatic hyperplasia Prostate Cancer Prostatic, DiS 2020; 23: 303-308 13. Mollengarden D, Goldberg K, Wong D, Roehrborn C. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience Prostate Cancer Prostatic, DiS 2018; 21: 379–385 JARNÍ EDUKA Č NÍ UROLOGICKÉ SYMPÓZIUM 2022 22. – 23. 4. 2022 LH Hotel Dvo ř ák, Tábor Záštita: Č eské urologické spole č nosti Č LS JEP Č eské akademie urologie Č US Č LS JEP Po ř adatel: Č eská urologická spole č nost Č LS JEP Organiza č ní zajišt ě ní: